logo
Google Reviews Logo

317.636.6481

One Indiana Square, Suite 1400 Indianapolis, Indiana 46204

Make a Payment
logo
CONTACT US
CALL US
  • Home
  • Firm Overview
  • Our Attorneys
  • Practice Areas
    • Pharmaceutical Drug & Medical Device Litigation
    • Personal Injury
    • Sexual Abuse
    • Class Action
    • Medical Malpractice
    • Eminent Domain
    • Family Law
    • Business Services, Real Estate & Business Litigation
    • Bankruptcy, Creditor’s Rights, & Commercial & Business Law
    • Appellate Law
  • Firm News
    • News & Announcements
    • Alerts
  • Resources
    • Video Library
    • Blog
  • Contact Us
Google Reviews Logo

317.636.6481

One Indiana Square, Suite 1400 Indianapolis, Indiana 46204

Make a Payment
  • Home
  • Firm Overview
  • Our Attorneys
  • Practice Areas
    • Pharmaceutical Drug & Medical Device Litigation
    • Personal Injury
    • Sexual Abuse
    • Class Action
    • Medical Malpractice
    • Eminent Domain
    • Family Law
    • Business Services, Real Estate & Business Litigation
    • Bankruptcy, Creditor’s Rights, & Commercial & Business Law
    • Appellate Law
  • Firm News
    • News & Announcements
    • Alerts
  • Resources
    • Video Library
    • Blog
  • Contact Us

Home » Actos Manufacturer Faces Additional Lawsuits

Actos Manufacturer Faces Additional Lawsuits

The pharmaceutical manufacturer, Takeda, who markets the drugs Actos, Prevacid, Uloric, and others is now facing additional lawsuits from patients alleging injuries. The U.S. Food and Drug Administration (FDA) issued a safety announcement in September 2010 that indicated an increased risk for bladder cancer in patients taking Actos (pioglitazone) for the treatment of their Type II diabetes mellitus. While the FDA has not fully concluded its study of the drug, it has stated that patients should be aware of the increased risk for developing bladder cancer as a result of taking this drug.

Patients taking the drug Uloric, also manufactured and marketed by Takeda, for the treatment of gout have filed complaints alleging that Takeda failed to warn patients about dangerous side effects when using Uloric in combination with other drugs [the filing document is no longer available from the source]. Drug combination side effects can include: severe bleeding & kidney failure, bone marrow failure, and death.

Our product liability/personal injury experts can discuss your legal options with you if you or a loved one is experiencing any side effects after using Actos or other drugs to treat Type II diabetes, please contact Cohen & Malad, LLP to seek the compensation you deserve.

One Indiana Square Suite 1400
Indianapolis, Indiana 46204

Copyright ©  Cohen & Malad, LLP. All rights reserved.

Disclaimer  |  Privacy Policy

 

Schedule a free consultation Today
  • This field is for validation purposes and should be left unchanged.

Schedule a free consultation Today

  • This field is for validation purposes and should be left unchanged.

ALERTS

Former Speedway High School Teacher and Coach Faces Child Seduction Charges

The Marion County Prosecutor has charged Tyler Carmichael, a former teacher at Speedway High School and track .. Read More

SEE ALL ALERTS

In the News

Indiana Legal Services and Indiana State Bar Foundation Receive $90,000 donation from Cohen & Malad, LLP Class Action United Way of Central Indiana’s Center for Working Families Receives $32,000 from Cohen & Malad, LLP Settlement Funds Indianapolis Neighborhood Housing Partnership Receives $32,000 from Cohen & Malad, LLP Settlement Funds
READ OUR NEWS